What it is

Ipamorelin is a synthetic growth hormone secretagogue that acts as a ghrelin receptor (GHSR-1a) agonist. It was developed as a more selective GH-releasing compound compared with earlier secretagogues, aiming to reduce some off-target hormonal effects.

Ipamorelin is not FDA-approved.

Why people use it

Non-medical use typically aims to increase GH pulsatility to influence body composition, recovery, or sleep. These goals are not established indications, and the relationship between GH pulses, IGF-1, and real-world outcomes is complex.

History and origin

Ipamorelin appears in the literature as part of the late-1990s and early-2000s wave of GH secretagogue development, when multiple small peptides were explored for endocrine and GI motility applications.

How it works

Ipamorelin activates GHSR-1a, promoting GH release from pituitary somatotrophs. In contrast to GHRH analogs, ghrelin receptor agonism can also influence appetite and gastrointestinal motility pathways, although ipamorelin has been described as relatively selective for GH release in some contexts.

Evidence landscape

Evidence includes animal studies and human volunteer pharmacology work, plus preclinical investigations in areas such as gastrointestinal dysmotility. Evidence supporting broad “recovery” or “anti-aging” benefits in humans is limited.

Safety reality

Risks plausibly include endocrine side effects similar to other GH/IGF-1–elevating approaches, such as fluid retention and glucose metabolism changes, though the magnitude depends on exposure and individual susceptibility. As with other unapproved peptides, manufacturing quality and mislabeling are important practical hazards.

References

Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus (ClinicalTrials.gov). https://clinicaltrials.gov/study/NCT00672074

Ipamorelin vs placebo for recovery of gastrointestinal function (ClinicalTrials.gov). https://clinicaltrials.gov/study/NCT01280344

Do growth hormone-releasing peptides act as ghrelin secretagogues? (2001). https://pubmed.ncbi.nlm.nih.gov/11322495/